leukemia

Oncological drug developers have fierce competition for patients, both in trials and in market. But Moleculin Biotech Inc (NASDAQ: MBRX) rests secure, snugly insulated from the battle. “There’s a reason not a lot of people are playing in the sandbox we’re playing in,”...

H.C. Wainwright maintains Buy rating on TG Therapeutics Inc (NASDAQ: TGTX) as it welcomes the company’s amendment of a cancer study called GENUINE. Under GENUINE, TG is studying Ublituximab in combination with Ibrutinib versus Ibrutinib alone in patients with previously treated high-risk...

The Street Sweeper's Sonya Colberg published a scathing short thesis on Bio-Path Holdings Inc (NASDAQ: BPTH), a clinical-stage biotechnology company that focuses on developing drugs to fight cancer. Colberg's main criticism of the company is the fact that it "spent six years...

What if you could speak into your smartphone, describing your symptoms when you felt ill, and receive an accurate medical diagnosis that could help you decide whether what you had was as serious as a heart attack or more likely just heartburn? What if you could take a picture of a used car you...